Weybosset Research & Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Weybosset Research & Management's DGX Position: Q1 2019 in Review
Weybosset Research & Management sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 40,442 shares — an estimated $3.37M sold.
Weybosset Research & Management first reported a position in DGX in Q1 2015 and held it in 16 quarters. The position peaked at $4.42M in Q3 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.
- Weybosset Research & Management reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
- Weybosset Research & Management sold 40,442 Quest Diagnostics shares in Q1 2019, an estimated $3.37M.
- Weybosset Research & Management first reported a position in Quest Diagnostics in Q1 2015 and held it in 16 quarters.
- Weybosset Research & Management's Quest Diagnostics position peaked at $4.42M in Q3 2018.
- 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.
Based on Weybosset Research & Management's 13F filing for Q1 2019, filed 15 Apr 2019.